Malignant transformation of monoclonal gammopathy of undetermined significance: Cumulative incidence and prognostic factors

Leukemia and Lymphoma

Volumn 42, Issue 4, 2001, Pages 609-618

  Van De Donk, N ^a   De Weerdt, O ^a   Eurelings, M ^a   Bloem, A ^a   Lokhorst, H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cumulative incidence; Gammopathy of undetermined significance; MGUS; Monoclonal gammopathy; Multiple myeloma; Prognosis

Indexed keywords

IMMUNOGLOBULIN KAPPA CHAIN;

ADULT; ARTICLE; BONE MARROW CELL; CANCER INCIDENCE; CARCINOGENESIS; CELL COUNT; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE COURSE; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; IMMUNOCYTOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; PLASMA CELL; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; STATISTICAL ANALYSIS;

EID: 0034874428     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109099321     Document Type: Article

References (24)

1. A 20-Year Follow-up Study of 64 Subjects with M-components
2. Monoclonal gammopathy of undetermined significance and solitary plasmacytoma. Implications for progression to overt multiple myeloma
3. "Benign" monoclonal gammopathy-after 20 to 35 years of follow-up
4. Measurement of apoptosis and proliferation of bone marrow plasma cells in patients with plasma cell proliferative disorders
5. Clinical, morphological, and cell kinetic differences among multiple myeloma, monoclonal gammopathy of undetermined significance, and smoldering multiple myeloma
6. Immunofluorescence labeling indices in myeloma and related monoclonal gammopathies
7. Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy
8. Blood clonal B-cell excess in patients with monoclonal gammopathy of undetermined significance (MGUS): Association with malignant transformation
9. Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: A prospective study of 87 bone biopsies
10. Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma
11. 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma
12. Advances in the diagnosis and management of myeloma
13. Staging and kinetics of multiple myeloma
14. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997
15. Determination of the plasma cell labelling index with bromodeoxyuridine in a double fluorescence technique
16. Determination of the growth fraction in monoclonal gammopathy with the monoclonal antibody Ki-67
17. Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance
18. Prognosis in monoclonal gammopathy of undetermined significance
19. Malignant transformation of monoclonal gammopathy of undetermined significance among out-patients of a community hospital in southeastern Netherlands
20. Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma
21. Improved cytogenetics in multiple myeloma: A study of 151 patients including 117 patients at diagnosis
22. Predictive role of interphase cytogenetics for survival of patients with multiple myeloma
23. Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization. Multicenter Investigation of Bone Sickle Cell Disease
24. Predictive role of interphase cytogenetics for survival of patients with multiple myeloma